Your browser doesn't support javascript.
loading
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial.
Krausz, Máté; Uhlmann, Annette; Rump, Ina Caroline; Ihorst, Gabriele; Goldacker, Sigune; Sogkas, Georgios; Posadas-Cantera, Sara; Schmidt, Reinhold; Feißt, Manuel; Alsina, Laia; Dybedal, Ingunn; Recher, Mike; Warnatz, Klaus; Grimbacher, Bodo.
Affiliation
  • Krausz M; Department of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany.
  • Uhlmann A; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Breisacher Straße 115, 79106 Freiburg, Germany.
  • Rump IC; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Schaenzlestraße 1, 79104, Freiburg, Germany.
  • Ihorst G; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Breisacher Straße 115, 79106 Freiburg, Germany.
  • Goldacker S; Clinical Trials Unit, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Elsaesser Straße 2, 79110 Freiburg, Germany.
  • Sogkas G; Department of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany.
  • Posadas-Cantera S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Breisacher Straße 115, 79106 Freiburg, Germany.
  • Schmidt R; Clinical Trials Unit, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Elsaesser Straße 2, 79110 Freiburg, Germany.
  • Feißt M; Department of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany.
  • Alsina L; Hannover Medical School, Klinik für Rheumatologie und Immunologie, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Dybedal I; Department of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany.
  • Recher M; Hannover Medical School, Klinik für Rheumatologie und Immunologie, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Warnatz K; Medical Center - University of Heidelberg, Institut für Medizinische Biometrie und Informatik, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
  • Grimbacher B; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Germany.
Contemp Clin Trials Commun ; 30: 101008, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36262801
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline Aspects: Patient_preference Language: En Journal: Contemp Clin Trials Commun Year: 2022 Document type: Article Affiliation country: Alemania Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline Aspects: Patient_preference Language: En Journal: Contemp Clin Trials Commun Year: 2022 Document type: Article Affiliation country: Alemania Country of publication: Países Bajos